Evidence map›Paper›PMID 31780884›Full record

ReviewFrontiers in neuroscience2019

The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer.

Olivier Soriani, Saïd Kourrich

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Mitochondria-ER crosstalk via MAMS: Bridging cellular homeostasis and cancer progression.Apoptosis : an international journal on programmed cell death · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Role of autophagy in angiogenic potential of vascular pericytes.Frontiers in cell and developmental biology · 2024
    Review
  8. Review
  9. Sigma-1 receptor and seizures.Pharmacological research · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Differentially Expressed Genes inBiomolecules & therapeutics · 2022
    Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 3 countries.

Olivier SorianiInserm, CNRS, iBV, Université Côte d'Azur, Nice, France.
Saïd KourrichDépartement des Sciences Biologiques, Université du Québec à Montréal, Montréal, QC, Canada.
Centre National de la Recherche Scientifique · FRUniversité du Québec à Montréal · CA

Funding

Role of Extinction in Circuit-Specific Modulation of Motivation and Mood in Cocaine AddictionR01DA041390 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI SELF, DAVID W · 2017 to 2021
$1.8M
Action of psychostimulant drugs on neuronal intrinsic excitability and drug-seeking behaviorR01DA045660 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI KOURRICH, SAID · 2018 to 2022
$1.5M
NIDA NIH HHS R01 DA041390NIDA NIH HHS R01 DA045660
6 · The paper itself

Abstract

The sigma-1 receptor (σ1R) is an endoplasmic reticulum (ER)-resident chaperone protein that acts like an inter-organelle signaling modulator. Among its several functions such as ER lipid metabolisms/transports and indirect regulation of genes transcription, one of its most intriguing feature is the ability to regulate the function and trafficking of a variety of functional proteins. To date, and directly relevant to the present review, σ1R has been found to regulate both voltage-gated ion channels (VGICs) belonging to distinct superfamilies (i.e., sodium, Na

Indexed as

cancerchaperone proteindrug addictionintrinsic excitabilitynervous system disordersplasticitysigma-1 receptorvoltage-gated ion channels

Identifiers

PMID31780884
PMCPMC6861184
OpenAlexW2984755739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.